Corrigendum to "Dose bridging data for mometasone furoate in once-daily fixed-dose inhaled combinations of mometasone furoate/indacaterol and mometasone furoate/indacaterol/glycopyrronium in patients with asthma" [Pulm. Pharmacol. Therapeut. 70 (2021) 102068]

Affiliations

• ¹ Pulmonary Department, Mainz University Hospital, Mainz, Germany.
• ² Novartis Pharma AG, Basel, Switzerland.
• ³ Novartis Institutes for BioMedical Research, Translational Medicine, Basel, Switzerland. Electronic address: hanns-christian.tillmann@novartis.com.
• ⁴ Novartis Institutes for BioMedical Research, Cambridge, MA, USA; Axcella Health Inc., Cambridge, MA, USA.
• ⁵ Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
• ⁶ University of Groningen, University Medical Center Groningen and Groningen Research Institute for Asthma and COPD, Groningen, the Netherlands.